Walgreens-Rite Aid Merger: How Will The Combined Entity Compare With CVS?

73.99
Trefis
WAG: Walgreen logo
WAG
Walgreen

Last year, Walgreens (NASDAQ:WBA) announced its plans to acquire Rite Aid (NYSE: RAD) in a deal worth $17.2 billion. After the completion of the deal, which is expected to close in the second half of 2016, Rite Aid will be a wholly owned subsidiary of Walgreens Boots Alliance, and is expected to initially operate under its existing brand name. Walgreens expects the transaction to be accretive in its first year after completion, and also expects to realize annual synergies in excess of $1 billion.

The Walgreens-Rite Aid combination will become a strong competitor for CVS, the largest pharmacy retail company, both in terms of revenues and earnings. Below we compare the sales and EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) of the combined Walgreens-Rite Aid entity with those of CVS.

Screen Shot 2016-06-15 at 6.56.15 PM

Relevant Articles
  1. Will Johnson & Johnson Stock Rebound To Its Pre-Inflation Shock Highs of $185?
  2. Should You Pick Eli Lilly Stock After A 4x Rise In Three Years?
  3. Down 9% This Year, What’s Next For Lululemon’s Stock Past Q4 Results?
  4. Down 14% In The Last Trading Session, Where Is Adobe Stock Headed?
  5. Will Higher Federal Government Spending, Gen AI Drive Digital Security Stocks Like CrowdStrike Higher?
  6. Up 30% In A Year Is FedEx Stock A Better Pick Over UPS?

We expect the revenues of the combined entity to be less than that of CVS, while the EBITDA margins will be similar to CVS’.

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com.
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our analysis for Walgreens

View Interactive Institutional Research (Powered by Trefis):

Global Large Cap | U.S. Mid & Small Cap | European Large & Mid Cap

More Trefis Research